Verus Capital Partners LLC Boosts Holdings in The Joint Corp. (NASDAQ:JYNT)

Verus Capital Partners LLC grew its position in shares of The Joint Corp. (NASDAQ:JYNT) by 5.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 132,955 shares of the company’s stock after buying an additional 7,440 shares during the period. Verus Capital Partners LLC owned about 0.89% of Joint worth $1,521,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of JYNT. Renaissance Technologies LLC grew its position in Joint by 5.5% in the 2nd quarter. Renaissance Technologies LLC now owns 394,478 shares of the company’s stock valued at $5,546,000 after buying an additional 20,400 shares in the last quarter. First Foundation Advisors boosted its position in Joint by 18.8% during the first quarter. First Foundation Advisors now owns 209,301 shares of the company’s stock valued at $2,733,000 after purchasing an additional 33,104 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Joint by 9.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 194,139 shares of the company’s stock valued at $2,730,000 after buying an additional 17,268 shares in the last quarter. Clayton Partners LLC lifted its stake in shares of Joint by 38.1% in the 2nd quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock valued at $2,622,000 after purchasing an additional 51,500 shares during the last quarter. Finally, O Brien Greene & Co. Inc grew its holdings in Joint by 0.9% during the second quarter. O Brien Greene & Co. Inc now owns 115,620 shares of the company’s stock valued at $1,626,000 after purchasing an additional 1,000 shares during the last quarter. Institutional investors own 76.88% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. StockNews.com cut Joint from a “buy” rating to a “hold” rating in a research report on Thursday, November 7th. Roth Mkm lowered their price objective on Joint from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Friday.

Joint Stock Performance

JYNT opened at $12.58 on Tuesday. The Joint Corp. has a 52-week low of $8.26 and a 52-week high of $17.82. The business’s fifty day moving average is $11.28 and its 200-day moving average is $12.97. The firm has a market cap of $188.70 million, a P/E ratio of -11.04 and a beta of 1.57.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.